Search
for

    Sort by

    Research 241–270 of 267

    1. Pharmacological Activity of Cepharanthine 2023 · 3 citations
    2. Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects PLOS ONE · 2021 · 3 citations
    3. Recent Insight on the Management of Lupus Erythematosus Alopecia Clinical, Cosmetic and Investigational Dermatology · 2021 · 3 citations
    4. Childhood‐onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report Pediatric rheumatology online journal · 2021 · 3 citations
    5. Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series Dermatology Practical & Conceptual · 2024 · 2 citations
    6. Unusual Case Presentation of Systemic Lupus Erythematosus in a Young Woman Rheumato · 2022 · 2 citations
    7. Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus F1000Research · 2022 · 1 citations
    8. A Case of Neuropsychiatric Systemic Lupus Erythematosus With Hair Loss as the First Diagnostic Symptom Frontiers in Psychiatry · 2022 · 1 citations
    9. Prevalence of thyroid dysfunction in patients with systemic lupus erythematosus: A descriptive cross sectional study Indian Journal of Rheumatology · 2020 · 1 citations
    10. Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review Dermatology and Therapy · 2026
    11. Parry–Romberg Syndrome: Radioclinical Dissociation in a Paucisymptomatic Form and a Proposed Diagnostic Framework Diagnostics · 2026
    12. Gender-Affirming Hormonal Treatment in Transgender People Assigned Female at Birth (AFAB) Endocrinology · 2026
    13. Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion npj Breast Cancer · 2025
    14. When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review Journal of Dermatological Treatment · 2025
    15. Klinisch redeneren: diagnostiek bij thyreotoxicose in de eerste lijn: een case-report Tijdschrift voor Geneeskunde · 2025
    16. Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark Lupus · 2024
    17. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies International Journal of Nanomedicine · 2024
    18. Progress in Research and Prospects for Application of Precision Gene-Editing Technology Based on CRISPR–Cas9 in the Genetic Improvement of Sheep and Goats Agriculture · 2024
    19. Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 2 approved] Faculty of 1000 Research Ltd · 2024
    20. Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study Frontiers in medicine · 2023
    21. Efficacy of autologous platelet‐rich plasma combined with a non‐cross‐linked hyaluronic acid compound in the treatment of female androgenetic alopecia: A retrospective, case‐series study Journal of Cosmetic Dermatology · 2023
    22. Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus F1000Research · 2022
    23. Atypical Presentation of Systemic Lupus Erythematous with Vasculitic Polyneuropathy Exclusive Real World Evidence Journal · 2022
    24. Juvenile systemic lupus erythematosus presenting only as nonscarring alopecia Indian Journal of Paediatric Dermatology · 2022
    25. Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 1 approved] Faculty of 1000 Research Ltd · 2022
    26. SnapshotDx Quiz: February 2018 Journal of Investigative Dermatology · 2018
    27. Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024 Pharmaceuticals · 2025 · 8 citations
    28. LO-010 Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus 2023
    29. THE OCCURRENCE OF DISCOID LUPUS ERYTHROMATOSUS PROGRESSING TO SYSTEMIC LUPUS ERYTHEMATOSUS, WITH OVERLAPPING ANCA-ASSOCIATED VASCULITIS, AND RHEUMATOID ARTHRITIS PRESENTING AS PAPULAR-PURPURIC GLOVE AND SOCK SYNDROME The Journal of Rheumatology · 2025
    30. Comprehensive Evaluation of Neuropsychiatric and Mucocutaneous Manifestations in the Diagnosis of Systemic Lupus Erythematosus: A Complete Clinical Approach to a Case Curēus · 2023